SNN
Price
$24.63
Change
+$0.04 (+0.16%)
Updated
Nov 13, 03:37 PM (EDT)
104 days until earnings call
SYK
Price
$388.99
Change
+$1.88 (+0.49%)
Updated
Nov 13, 03:39 PM (EDT)
83 days until earnings call
Ad is loading...

SNN vs SYK

Header iconSNN vs SYK Comparison
Open Charts SNN vs SYKBanner chart's image
Smith & Nephew
Price$24.63
Change+$0.04 (+0.16%)
Volume$588
CapitalizationN/A
Stryker
Price$388.99
Change+$1.88 (+0.49%)
Volume$138
CapitalizationN/A
SNN vs SYK Comparison Chart
Loading...
SNN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SNN vs. SYK commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNN is a StrongSell and SYK is a StrongBuy.

COMPARISON
Comparison
Nov 13, 2024
Stock price -- (SNN: $24.58 vs. SYK: $387.11)
Brand notoriety: SNN and SYK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SNN: 179% vs. SYK: 147%
Market capitalization -- SNN: $10.95B vs. SYK: $134.94B
SNN [@Medical Specialties] is valued at $10.95B. SYK’s [@Medical Specialties] market capitalization is $134.94B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNN’s FA Score shows that 1 FA rating(s) are green whileSYK’s FA Score has 3 green FA rating(s).

  • SNN’s FA Score: 1 green, 4 red.
  • SYK’s FA Score: 3 green, 2 red.
According to our system of comparison, SYK is a better buy in the long-term than SNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNN’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 5 bullish TA indicator(s).

  • SNN’s TA Score: 4 bullish, 4 bearish.
  • SYK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SYK is a better buy in the short-term than SNN.

Price Growth

SNN (@Medical Specialties) experienced а -3.83% price change this week, while SYK (@Medical Specialties) price change was +4.66% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.21%. For the same industry, the average monthly price growth was +2.00%, and the average quarterly price growth was -2.98%.

Reported Earning Dates

SNN is expected to report earnings on Feb 25, 2025.

SYK is expected to report earnings on Feb 04, 2025.

Industries' Descriptions

@Medical Specialties (+0.21% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($135B) has a higher market cap than SNN($10.9B). SYK has higher P/E ratio than SNN: SYK (42.99) vs SNN (40.76). SYK YTD gains are higher at: 30.159 vs. SNN (-7.339). SYK has higher annual earnings (EBITDA): 4.93B vs. SNN (956M). SYK has more cash in the bank: 3.05B vs. SNN (302M). SNN has less debt than SYK: SNN (3.08B) vs SYK (13B). SYK has higher revenues than SNN: SYK (20.5B) vs SNN (5.55B).
SNNSYKSNN / SYK
Capitalization10.9B135B8%
EBITDA956M4.93B19%
Gain YTD-7.33930.159-24%
P/E Ratio40.7642.9995%
Revenue5.55B20.5B27%
Total Cash302M3.05B10%
Total Debt3.08B13B24%
FUNDAMENTALS RATINGS
SNN vs SYK: Fundamental Ratings
SNN
SYK
OUTLOOK RATING
1..100
718
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
20
Undervalued
PROFIT vs RISK RATING
1..100
10014
SMR RATING
1..100
9349
PRICE GROWTH RATING
1..100
6324
P/E GROWTH RATING
1..100
8970
SEASONALITY SCORE
1..100
750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNN's Valuation (5) in the Medical Specialties industry is in the same range as SYK (20). This means that SNN’s stock grew similarly to SYK’s over the last 12 months.

SYK's Profit vs Risk Rating (14) in the Medical Specialties industry is significantly better than the same rating for SNN (100). This means that SYK’s stock grew significantly faster than SNN’s over the last 12 months.

SYK's SMR Rating (49) in the Medical Specialties industry is somewhat better than the same rating for SNN (93). This means that SYK’s stock grew somewhat faster than SNN’s over the last 12 months.

SYK's Price Growth Rating (24) in the Medical Specialties industry is somewhat better than the same rating for SNN (63). This means that SYK’s stock grew somewhat faster than SNN’s over the last 12 months.

SYK's P/E Growth Rating (70) in the Medical Specialties industry is in the same range as SNN (89). This means that SYK’s stock grew similarly to SNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNNSYK
RSI
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
52%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 9 days ago
56%
Bullish Trend 2 days ago
58%
Declines
ODDS (%)
Bearish Trend 14 days ago
58%
Bearish Trend 20 days ago
51%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Ad is loading...
SNN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HIDV73.51-0.14
-0.20%
AB US High Dividend ETF
ESGB21.03-0.08
-0.36%
NYLI MacKay ESG Core Plus Bond ETF
DTEC45.69-0.42
-0.90%
ALPS Disruptive Technologies ETF
FBT174.79-3.05
-1.72%
First Trust NYSE Arca Biotech ETF
EFA77.71-1.47
-1.86%
iShares MSCI EAFE ETF

SNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNN has been loosely correlated with TFX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SNN jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNN
1D Price
Change %
SNN100%
-0.65%
TFX - SNN
58%
Loosely correlated
-1.23%
IDXX - SNN
43%
Loosely correlated
-2.56%
NSTM - SNN
43%
Loosely correlated
N/A
SYK - SNN
40%
Loosely correlated
+2.18%
MDT - SNN
39%
Loosely correlated
+0.03%
More

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been closely correlated with BSX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYK jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
+2.18%
BSX - SYK
67%
Closely correlated
+0.27%
ISRG - SYK
56%
Loosely correlated
+0.25%
ZBH - SYK
48%
Loosely correlated
+0.44%
MDT - SYK
44%
Loosely correlated
+0.03%
ABT - SYK
44%
Loosely correlated
-0.31%
More